Patents Assigned to Regents of the University of California
  • Patent number: 11958901
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to CXCR5. The antibodies can be afucosylated and exhibit increased ADCC compared with the otherwise identical fucosylated antibodies. The invention includes uses, and associated methods of using the antibodies.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: April 16, 2024
    Assignees: Pfizer Inc., The Regents of the University of California
    Inventors: Rachel Groth, William Brian Snyder, Xianjun Cao, Robert Joseph Dunn, Joseph Dal Porto, Michael Karin
  • Patent number: 11961667
    Abstract: Provided herein are devices comprising one or more cells, and methods for fabrication thereof. The devices may be electrochemical devices. The devices may include three-dimensional supercapacitors. The devices may be microdevices such as, for example, microsupercapacitors. In some embodiments, the devices are three-dimensional hybrid microsupercapacitors. The devices may be configured for high voltage applications. In some embodiments, the devices are high voltage microsupercapacitors. In certain embodiments, the devices are high voltage asymmetric microsupercapacitors. In some embodiments, the devices are integrated microsupercapacitors for high voltage applications.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: April 16, 2024
    Assignees: The Regents of the University of California, Nanotech Energy, Inc.
    Inventors: Maher F. El-Kady, Richard B. Kaner, Jack Kavanaugh
  • Patent number: 11957655
    Abstract: Provided are methods of treating various forms of hearing loss caused by aberrant calcium fluxes in auditory cells. The methods encompass the administration of agents which prevent abnormal calcium fluxes, stabilize SERCA2b activity, or prevent ER UPR apoptotic responses. The methods include therapeutic treatments of subjects suffering from hearing loss as well as preventative treatments which protect auditory cells from cell death, for example as caused by exposure to loud noise.
    Type: Grant
    Filed: October 22, 2016
    Date of Patent: April 16, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: Elliott Sherr
  • Publication number: 20240121636
    Abstract: Aspects of the subject disclosure may include, for example, training a cell-level machine learning model to predict a likelihood of a cell site in a cellular network having service issues that impact customers of the cellular network, training a user equipment (UE) level machine learning model using output information from the cell-level machine learning model and historical information about UE-level performance metrics, receiving, from a customer associated with a UE device operating on the cellular network, information about a service degradation experienced by the customer on the UE device, providing the information about the service degradation to the UE-level machine learning model; and receiving, from the UE-level machine learning model, information identifying a source of the service degradation. Other embodiments are disclosed.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 11, 2024
    Applicants: AT&T Intellectual Property I, L.P., The Regents of the University of California
    Inventors: Jia Wang, Amit Kumar Sheoran, Xiaofeng Shi, Chen Qian, Matthew Osinski
  • Publication number: 20240121628
    Abstract: Aspects of the subject disclosure may include, for example, categorizing users of a cellular network according to a plurality of user categories, identifying, by a machine learning model, a service degradation in the cellular network, identifying at least one affected user, the at least one affected user being affected by the service degradation, identifying one or more affected user categories including the at least one affected user, identifying potentially affected users, the potentially affected users being categorized according to the one or more affected user categories, and taking action to isolate the potentially affected users from the service degradation. Other embodiments are disclosed.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 11, 2024
    Applicants: AT&T Intellectual Property I, L.P., The Regents of the University of California
    Inventors: Jia Wang, Xiaofeng Shi, Amit Kumar Sheoran, Matthew Osinski, Chen Qian
  • Publication number: 20240118452
    Abstract: A metalens and a metalens array having a bounded angular field of view are disclosed. The metalens includes a substrate and a two-dimensional (2D) grid over the substrate to divide the substrate into a 2D array of meta-units. Each meta-unit in the 2D array includes a nanostructure and a portion of the substrate that supports the nanostructure. Moreover, each meta-unit is configured with an angular-dependent transmission or reflection coefficient that decreases with an increasing incident angle of an illumination. Moreover, the metalens passes an incident light having an incident angle less than a cutoff angle and rejects an incident light having an incident angle greater than the cutoff angle. The metalens can be used a base unit for constructing a metalens array by tiling copies of the metalens into a 2D array of the metalens to achieve a significantly larger field-of-view.
    Type: Application
    Filed: February 11, 2022
    Publication date: April 11, 2024
    Applicant: The Regents of the University of California
    Inventors: Weijian Yang, Junjie Hu
  • Publication number: 20240115564
    Abstract: Methods for treating diabetes are described. The methods include administration of a serotonin receptor 1F (HTR1F) antagonist, such as a substituted piperidine, methysergide, or methiothepin, to a subject in need thereof. Administration of the HTR1F antagonist can increase survival of pancreatic beta cells in conjunction with pancreatic islet transplantation. Methods for transplanting pancreatic islets to subjects such as diabetes patients are also described.
    Type: Application
    Filed: January 11, 2022
    Publication date: April 11, 2024
    Applicant: The Regents of the University of California
    Inventor: Gregory Ku
  • Publication number: 20240118284
    Abstract: The present disclosure relates generally to methods for preparing a tissue sample for detection of the expression of a transmembrane protein in the tissue sample. The present disclosure also provides antibodies and treatments targeting tumor samples expressing the PLXDC1 or the PLXDC2 proteins.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 11, 2024
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Hui SUN, Adrian Chichuen AU, Guo Cheng
  • Publication number: 20240115183
    Abstract: Systems and method for wireless recording system-on-chips for distributed neural interface systems with inductive power delivery and UWB data transmission are described. In an embodiment, the system includes an implantable neural interface including: an electrode array having several electrodes; front end circuitry including: one or more digital components, and at least one amplifier coupled to a first electrode and a second electrode of the electrode array, wherein the amplifier and the first electrode and the second electrode form a sensing channel configured to sense electrical activity; and a transceiver including: several digital components; a power harvesting system that receives RF energy through a wireless power link; and a wireless clock receiver that provides a clock signal to the one or more digital components of the front end circuitry and the several digital components of the transceiver.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 11, 2024
    Applicant: The Regents of the University of California
    Inventors: Hamed Rahmani, Aydin Babakhani
  • Patent number: 11952362
    Abstract: The present disclosure provides compounds and compositions capable of treating cancer or an autoimmune disease, such as Crohn's disease, and methods of use thereof.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Dimitrios Iliopoulos, Michael E. Jung, Jonghoon Kim, Jill M. Hoffman, Iordanes Karagiannides
  • Patent number: 11951176
    Abstract: Trehalose-based nanogels for stabilizing and controlled releasing biomolecules such as glucagons are disclosed. Specifically, trehalose-based nanogels comprise (a) a copolymer comprising first methacrylate units and second methacrylate units, wherein (i) the first methacrylate units comprise trehalose side chains; and (ii) the second methacrylate units comprise disulfide side chains; (b) dithiol cross-linkers; wherein the dithiol cross-linkers cross link the copolymer through the disulfide side chains of the second methacrylate units.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Heather D. Maynard, Natalie Boehnke
  • Patent number: 11950961
    Abstract: A computer vision pipeline is provided for fully automated interpretation of cardiac function, using a combination of machine learning strategies to enable building a scalable analysis pipeline for echocardiogram interpretation. Videos from patients with heart failure can be analyzed and processed as follows: 1) preprocessing of echo studies; 2) convolutional neural networks (CNN) processing for view identification; 3) segmentation of chambers and delineation of cardiac boundaries using CNNs; 4); particle tracking to compute longitudinal strain; and 5) targeted disease detection.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Rahul C. Deo, Jeffrey Zhang
  • Patent number: 11951682
    Abstract: A thermoresponsive suspension composition for use in additive manufacturing includes an aqueous suspension of a thermosetting resin, a crosslinking agent configured to react with the thermosetting resin, and a mineral particulate, wherein the thermosetting resin and crosslinking agent react at or above a trigger temperature.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: April 9, 2024
    Assignees: The Regents of the University of California, Technical University of Munich, Master Builders Solutions Admixtures US, LLC
    Inventors: Gaurav Sant, Sharu Bhagavathi Kandy, Torben Gädt, Iman Mehdipour, Thiyagarajan Ranganathan, Samanvaya Srivastava, Paul Seiler
  • Patent number: 11953607
    Abstract: Systems, device configurations, and processes are provided for navigation and determination of navigation observables based on low Earth orbit (LEO) satellite signals. A method for navigation includes using differential carrier phase measurement of LEO signals including correction of position estimates using integer ambiguity resolution and double difference carrier phase determinations. Frameworks described herein can use a computationally efficient integer ambiguity resolution to reduce the size of the integer least squares (ILS) determination. The framework may include a joint probability density function (pdf) of the megaconstellation LEO satellites' azimuth and elevation angle to characterize a LEO system. Embodiments are also directed to correction of ambiguities of carrier phase differential (CD)-low Earth orbit (LEO) (CD-LEO) measurements that may utilize a base and a rover without requiring prior knowledge of rover position.
    Type: Grant
    Filed: July 2, 2021
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Zak Kassas, Joe Khalife, Mohammad Neinavaie
  • Patent number: 11955241
    Abstract: The disclosure provides for pathogenic biomarkers and serum extracellular vesicular biomarkers that are associated with vascular anomalies and malformation of endothelial cells, and uses thereof, including for diagnosis, prognosis and therapy.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Wenbin Tan, John Stuart Nelson, Dongbao Chen
  • Patent number: 11951136
    Abstract: Provided herein, inter alia, are methods and compositions for treating diabetes mellitus comprising co-transplantation of an insulin-producing cell and a cell derived from a parathyroid gland (PTG), a CD34+ cell derived from a parathyroid gland, a CD34+ cell derived from a stem cell, or other progenitor cell-derived CD34+ cell.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 9, 2024
    Assignees: The Regents of the University of California, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Casey Ward, Qizhi Tang, Peter Stock, Gaetano Faleo, Gopika Nair, Matthias Hebrok, Wenhan Chang, Thuy Vo, Jeffrey A. Bluestone, Eleonora De Klerk
  • Publication number: 20240108698
    Abstract: Provided herein are klotho polypeptide compositions and methods for improving cognitive function in an individual comprising treatment of with klotho polypeptides.
    Type: Application
    Filed: June 28, 2023
    Publication date: April 4, 2024
    Applicant: The Regents of the University of California
    Inventor: Dena Dubal
  • Publication number: 20240109039
    Abstract: A membrane desalination system includes a housing, an electrically conductive membrane disposed within the housing, wherein the electrically conductive membrane includes a porous support and an electrically conductive layer disposed on the porous support, and the electrically conductive layer includes nanostructures, and an alternating current power source connected to the electrically conductive membrane.
    Type: Application
    Filed: December 1, 2021
    Publication date: April 4, 2024
    Applicant: The Regents of the University of California
    Inventors: David Jassby, Unnati Rao, Eric Hoek, Bongyeon Jung
  • Publication number: 20240114362
    Abstract: Aspects of the subject disclosure may include, for example, receiving, from a machine learning model, information about an event causing a service degradation in a cellular network, wherein the event is external to the cellular network, determining one or more event categories associated with the event causing the service degradation, determining, based on the one or more event categories, likely affected customers, the likely affected customers being likely to experience the service degradation, determining, by the machine learning model, proper resources for resolution of the service degradation, wherein the determining proper resources is based on the one or more event categories, and dispatching the proper resources for resolution of the service degradation. Other embodiments are disclosed.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Applicants: AT&T Intellectual Property I, L.P., The Regents of the University of California
    Inventors: Jia Wang, Amit Kumar Sheoran, Xiaofeng Shi, Matthew Osinski, Chen Qian
  • Patent number: PP35727
    Abstract: A new prune cultivar designated ‘UC G2S-8’ has been developed. The fruit of this cultivar are medium, yellow in color and covered with a grayish waxy bloom. The ‘UC G2S-8’ tree is productive and a regular bearer.
    Type: Grant
    Filed: April 12, 2023
    Date of Patent: April 9, 2024
    Assignee: The Regents of the University of California
    Inventors: Theodore M. DeJong, Sarah Castro, James F. Doyle, Carolyn DeBuse